Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Selenium speciation from food source to metabolites: a critical review.

Dumont E, Vanhaecke F, Cornelis R.

Anal Bioanal Chem. 2006 Aug;385(7):1304-23. Epub 2006 Jul 8. Review.

PMID:
16830114
2.

Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.

Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, Albanes D, Andriole GL, Urban DA, Peters U; PLCO Trial.

J Natl Cancer Inst. 2006 Feb 15;98(4):245-54.

3.

Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis.

Etminan M, FitzGerald JM, Gleave M, Chambers K.

Cancer Causes Control. 2005 Nov;16(9):1125-31.

PMID:
16184479
4.

Methods for etiologic and early marker investigations in the PLCO trial.

Hayes RB, Sigurdson A, Moore L, Peters U, Huang WY, Pinsky P, Reding D, Gelmann EP, Rothman N, Pfeiffer RM, Hoover RN, Berg CD; PLCO Trial Team.

Mutat Res. 2005 Dec 30;592(1-2):147-54. Epub 2005 Jul 27.

PMID:
16054167
5.

Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.

Meyer F, Galan P, Douville P, Bairati I, Kegle P, Bertrais S, Estaquio C, Hercberg S.

Int J Cancer. 2005 Aug 20;116(2):182-6.

6.

Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study.

Weinstein SJ, Wright ME, Pietinen P, King I, Tan C, Taylor PR, Virtamo J, Albanes D.

J Natl Cancer Inst. 2005 Mar 2;97(5):396-9.

7.

Development and application of a simple routine method for the determination of selenium in serum by octopole reaction system ICPMS.

Stürup S, Hayes RB, Peters U.

Anal Bioanal Chem. 2005 Feb;381(3):686-94. Epub 2005 Feb 9.

PMID:
15702311
8.

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM Jr, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA Jr.

J Natl Cancer Inst. 2005 Jan 19;97(2):94-102.

9.

The effect of prostate cancer and antiandrogenic therapy on lipid peroxidation and antioxidant systems.

Iynem AH, Alademir AZ, Obek C, Kural AR, Konukoğlu D, Akçay T.

Int Urol Nephrol. 2004;36(1):57-62.

PMID:
15338676
10.

Status of selenium in prostate cancer prevention.

Combs GF Jr.

Br J Cancer. 2004 Jul 19;91(2):195-9. Review.

11.

A prospective study of plasma selenium levels and prostate cancer risk.

Li H, Stampfer MJ, Giovannucci EL, Morris JS, Willett WC, Gaziano JM, Ma J.

J Natl Cancer Inst. 2004 May 5;96(9):696-703.

12.

A case--control study of selenium in nails and prostate cancer risk in British men.

Allen NE, Morris JS, Ngwenyama RA, Key TJ.

Br J Cancer. 2004 Apr 5;90(7):1392-6.

13.

Synergistic effect of vitamin E and selenium in human prostate cancer cell lines.

Venkateswaran V, Fleshner NE, Klotz LH.

Prostate Cancer Prostatic Dis. 2004;7(1):54-6.

PMID:
14745439
14.

Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling.

Dong Y, Lee SO, Zhang H, Marshall J, Gao AC, Ip C.

Cancer Res. 2004 Jan 1;64(1):19-22.

16.

Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells.

Zhao H, Whitfield ML, Xu T, Botstein D, Brooks JD.

Mol Biol Cell. 2004 Feb;15(2):506-19. Epub 2003 Nov 14.

18.

Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study.

van den Brandt PA, Zeegers MP, Bode P, Goldbohm RA.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):866-71.

19.

The thioredoxin-thioredoxin reductase system: over-expression in human cancer.

Lincoln DT, Ali Emadi EM, Tonissen KF, Clarke FM.

Anticancer Res. 2003 May-Jun;23(3B):2425-33.

PMID:
12894524
20.
Items per page

Supplemental Content

Write to the Help Desk